31686-64-3Relevant articles and documents
NAPHTHYRIDINES AS INHIBITORS OF HPK1
-
Paragraph 2238; 2239, (2018/10/21)
Naphthyridine compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the naphthyridine compounds.
LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE
-
Paragraph 0389-0390, (2017/10/26)
A novel organometallic complex with high reliability is provided. A light-emitting element includes an EL layer between a pair of electrodes. The EL layer includes at least a light-emitting layer. The light-emitting layer contains an organometallic complex. The organometallic complex includes a first ligand and a second ligand which are coordinated to a central metal. The HOMO is distributed over the first ligand, and the LUMO is distributed over the second ligand. The first ligand and the second ligand are cyclometalated ligands.
ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
-
Paragraph 0351, (2016/07/27)
An organometallic compound represented by Formula 1: [in-line-formulae]M(L1)n1(L2)n2??Formula 1[/in-line-formulae]wherein in Formula 1, M, L1, L2, n1, and n2 are the same as described in th